Author

F. Tan

h-index 0 View on Semantic Scholar

We have 3 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Associations between glucolipid metabolic indices with the risk and progression of cardiovascular-kidney-metabolic syndrome in MASLD: evidence from the UK biobank

Metabolic dysfunction–associated steatotic liver disease (MASLD) affects nearly one-third of the global population and increases the risk of adverse hepatic and extrahepatic outcomes. However, its contribution to multimorbidity trajectories remains insufficiently defined. The current Cardiovascular -Kidney-Metabo...

R. Wang, F. Tan, J. Yuan et al. · European Heart Journal · 0 citations

Open access Oct 2026

Association of Life's Essential 8 and psoriasis-atherosclerotic cardiovascular disease (PSO-ASCVD) comorbidity: a prospective cohort study

Among individual LE8 metrics, biological components (glucose, BMI) and behavioral domains (diet, activity, sleep, nicotine) were the major contributors to reduced PSO-ASCVD risk.

F. Tan, M. Wang, Y. Jiang et al. · European Heart Journal · 0 citations

Open access Oct 2026

Single-cell transcriptomic landscape of psoriasis-accelerated atherosclerosis reveals immune remodeling and macrophage dysfunction

Psoriasis, a chronic inflammatory skin disease, confers a significantly increased risk of atherosclerosis and cardiovascular events. However, the cellular and molecular mechanisms underlying this accelerated atherosclerosis remain poorly understood at single-cell resolution. We performed single-cell RNA se...

F. Tan, R. Wang, Y. Jiang et al. · European Heart Journal · 0 citations